General description
enthält (15,00 € Patentgebühr für DM Exon 2): Degenerative Myelopathie (DM Exon 2), Neuronale Ceroidlipofuszinose (NCL)**, Progressive Retinaatrophie (crd1-PRA), D-Lokus d1 (Farbverdünnung)
American Staffordshire Terrier
Order details
| Test number | 8832 |
| Sample material | 0,5 ml EDTA Blut, 2x Backenabstrich, 1x Spezialabstrich (eNAT) |
| Test duration | 7-14 Werktage |
D-locus d1 (dilution)
Test specifications
| Inheritance | Allelic series: D dominant over d1, d2 and d3 |
| Gene | MLPH |
| Mutation | G-A |
| Literature | OMIA:000031-9615 |
Degenerative myelopathy exon 2 (DM exon 2)
Test specifications
| Symptom complex | neuromuscular |
| Inheritance | autosomal recessive with age-dependent incomplete penetrance; a risk factor associated with DM is detected. |
| Age of onset | ab 8 years |
| Causality | High-risk factor |
| Gene | SOD1 |
| Mutation | G-A |
| Literature | OMIA:000263-9615 |
Progressive retinal atrophy (crd1-PRA)
Test specifications
| Symptom complex | ophthalmic |
| Inheritance | autosomal recessive |
| Age of onset | 6 months |
| Causality | causally |
| Gene | PDE6B |
| Mutation | DEL |
| Literature | OMIA:001674-9615 |
Neuronal ceroid lipifuscinosis (NCL) - American Staffordshire Terrier
Test specifications
| Symptom complex | neurological |
| Inheritance | autosomal recessive |
| Causality | causally |
| Gene | ARSG |
| Mutation | G-A |
| Literature | OMIA:001503-9615 |
